🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

key points in "N" lymph nodes in oligometastasis: - Patient N2 and N3 leave the surgical benefit because they have no curative intention. (Residual disease generates oligoprogression - futile surgery)

KEY POINTS IN OLIGOMETASTASI SURGERY: -Optimal general conditions (tolerate all systemic + surgical treatment and/or radiotherapy) -Nodal involvement N0 (invasive mediastinal staging) -Tumor size T1 or T2 more than T3-T4 -Response or absence of progression during systemic tto

KEY POINTS IN OLIGOMETASTASI SURGERY: - Extrathoracic metastatic lesion (Brain and Adrenal Gland) - Real possibility of R0 resection at all sites (curative) - Treatment strategy (must be in conjunction with the multidisciplinary team)-There is not a single answer.

Surgery in Mesothelioma: Appropriate selection of the surgical candidate and thorough patient staging is crucial for patient outcomes. Surgery must be integrated as a multimodal strategy of systemic treatment and radiotherapy.

Surgery in mesothelioma: should be carried out in a multidisciplinary group and in a center of expertise, limiting the rate of postoperative complications. Clinical trials will allow surgery to be maintained as a therapeutic option in patients with curative intent.

Me: It is not about chemotherapy vs surgery, it is about focusing the patient on the best scenario of clinical trials, depending on the characteristics of the disease. Surgeons will have to fight so that the surgical technique has fewer side effects and survives medical therapy

Training the nursing department on the pleural drainage system is essential to maintain safe medical care.

Metastasectomia en Cancer de Colon y Recto... Aun sigue Teniendo un Campo Muy grande en la cirugia de torax (Sincronico y Metacronico)!!!

Indicaciones de Manejo Quirurgico Por Cirugia de Torax en Pacientes con Neumotorax espontaneo !

Esofaguectomia de calidad

Thymic carcinoma !!! Be Careful ...

So important to remember - continuation of pemetrexed maintenance on the #FLAURA2 likely is required to derive benefit! Julia Rotow MD @asco #ASCO25 EGFR Resisters Dana Farber's EGFR Mutant Lung Cancer Center #LCSM

#ASCO25 Julia Rotow MD Dana-Farber elegantly presents the case for #osimertinib Monotherapy over combination strategies (FLAURA2, MARIPOSA) ▶️ Reserving combination for higher risk pts ▶️ Maximixing each therapy in sequential approach ▶️ Shared decision w patients EGFR Resisters

Preoperative chemoimmunotherapy followed by surgery and postoperative immunotherapy in lung cancer: limited compliance for all planned therapy #ASCO25 ⁦OncoAlert⁩

Excited for the #LCSM session today at #ASCO25! 🚨 Here’s the latest treatment algorithm for advanced/metastatic #NSCLC 👇 How will it change after today?🔥 Can’t wait to see where new agents & trial data may fit in! LungCancerRx 🫁💊 Hem-Onc Fellows Network @Oncoalert Oncology Brothers

About lung cancer! …

🫁 Summary of immunotherapies early stage NSCLC 1/3 ⭐️ Key clinical data as of June 2025 ※ #ASCO25 data included.

Complex Esophageal Reconstruction for patients who need #esophagealReplacement as seen in the The Annals of Thoracic Surgery pubmed.ncbi.nlm.nih.gov/40274211/

Advances in molecular pathology and therapy of non-small cell lung cancer 💫An exceptionally comprehensive review (72 pages 👀) Algorithms👇 nature.com/articles/s4139…

We are thrilled to welcome internationally renowned cardiovascular surgeon Juan Pablo Umaña, M.D., to @UMiamiMedicine and UHealth as our new Chief of Cardiothoracic Surgery! ❤️ Dr. Umaña is a global leader in aortic and mitral valve repair, the founder of the Latin-American